Course Description

GCP for Investigators: Clinical Investigation Close out or Termination

Course Description:

In this course we will review under what circumstances a clinical investigation may need to be suspended or prematurely terminated and the role of each party involved. We will further outline all major activities required in order to close a clinical investigation, including all necessary reporting to sponsor, ethics committee or IRB and competent authority or FDA.

This course has been developed according to the requirements outlined in:

  • ISO 14155:2011 – Clinical Investigation of medical devices for human subjects – Good clinical practice
  • 21 CRF part 812 – Investigational device exemption
  • Declaration of Helsinki
  • 21 CRF part 50 – Protection of Human Subjects.

Watch the Course Trailer:



Learning Objectives:

Upon completion of this course, trainees will be able to correctly and successfully:

  • Perform the appropriate actions when a suspension or premature termination of a clinical investigation is needed and/or perform all close out activities necessary at the end of a clinical investigation.

Who Should Enroll:

Principal and co-investigators, study coordinators, site managers, and other hospital staff or ancillary staff involved in the clinical side of a medical device clinical investigation.

Prerequisite Knowledge/Requirements:

Learners must have an understanding of what a clinical investigation is about and a basic understanding of the medical device regulatory and good clinical practices environment. Introduction to medical devices (ID 193), how to qualify for a medical device clinical investigation (ID 200), ethics and legal processes (ID 212), initiating a clinical investigation (ID 202), and conduct of and reporting during a clinical investigation (ID 204) provide the pre-requisite knowhow.

Subject Matter Expert:
Danielle Giroud

23 min

Release date:

Related resources:

Case studies:

Basic Account: € 60.00
Premium Account: € 45.00

Change Currency:
Add to cart